Newsfeeds - Spark Newswire

1 minute read

Today, 2:42 AM

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") has officially been granted by NASDAQ an additional period until July 3, 2023 to regain compliance with NASDAQ listing requirements, the Company

NYMX

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 2:42 AM

Gainers Nymox Pharmaceutical (NASDAQ:NYMX) stock moved upwards by 20.7% to $0.52 during Monday’s after-market session. The market value…

ALGS

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 2:42 AM

Gainers Baudax Bio (NASDAQ:BXRX) stock moved upwards by 61.2% to $6.56 during Friday’s pre-market session. The company’s market…

AMAM

4 minute read

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 2:42 AM

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

AMAM

3 minute read

S&P 500 Down 2%; Nasdaq Drops 250 Points

By Lisa Levin

Today, 2:42 AM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 550 points on Monday.

CPHI

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 2:42 AM

Gainers Nymox Pharmaceutical (NASDAQ:NYMX) shares increased by 32.7% to $0.38 during Monday’s regular session. As of 12:30 EST,…

AMPE

3 minute read

Gold Down 1%; China Pharma Shares Spike Higher

By Lisa Levin

Today, 2:42 AM

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 200 points on Monday.

CPHI

1 minute read

NYMOX Announces New Marketing Submission For NYMOZARFEX For Benign Prostatic Hyperplasia

By Benzinga Newsdesk

Today, 2:42 AM

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") is pleased to announce today that a new formal submission has been made by the Company in Europe for Fexapotide Triflutate for the treatment of

NYMX